Stockscreener 앱 받기
5.25
2.60%
-0.14
시장 영업 전:
5.26
0.010
+0.19%
Iteos Therapeutics Inc 주식(ITOS)의 최신 뉴스
KLP Kapitalforvaltning AS Acquires New Position in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
Raymond James Financial Inc. Buys New Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
Iteos Therapeutics stock hits 52-week low at $5.56 amid market challenges - Investing.com Australia
Iteos Therapeutics stock hits 52-week low at $5.56 amid market challenges By Investing.com - Investing.com South Africa
iTeos Therapeutics, Inc. (NASDAQ:ITOS) Shares Bought by Virtu Financial LLC - Defense World
Charles Schwab Investment Management Inc. Sells 22,939 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
Charles Schwab Investment Management Inc. Decreases Position in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - The AM Reporter
Bank of New York Mellon Corp Sells 35,918 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
Iteos Therapeutics Inc Stock: Cancer Drug Pipeline Shows Promise - Sharewise
iTeos to Present Preclinical Data on Potential Best-In-Class Anti-TREM2 Antibody, EOS-215, and Novel PTPN1/2 Inhibitor at the American Association for Cancer Research Annual Meeting 2025 - GlobeNewswire
Game-Changing Cancer Drug Data: iTeos Reveals Best-in-Class Antibody Results at AACR - Stock Titan
Long Term Trading Analysis for (ITOS) - news.stocktradersdaily.com
Victory Capital Management Inc. Has $782,000 Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
US Bancorp DE Acquires 4,843 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
Wall Street Analysts Think iTeos Therapeutics (ITOS) Could Surge 212.5%: Read This Before Placing a Bet - Yahoo Finance
(ITOS) Investment Report - news.stocktradersdaily.com
Research Analysts Offer Predictions for ITOS Q1 Earnings - Defense World
Analysts Set Expectations for ITOS FY2029 Earnings - Defense World
Wells Fargo & Company Issues Pessimistic Forecast for iTeos Therapeutics (NASDAQ:ITOS) Stock Price - Defense World
HC Wainwright Reaffirms “Buy” Rating for iTeos Therapeutics (NASDAQ:ITOS) - Defense World
JPMorgan Chase & Co. Issues Pessimistic Forecast for iTeos Therapeutics (NASDAQ:ITOS) Stock Price - Defense World
iTeos Therapeutics: Poised for Success with Anti-TIGIT Therapies Amidst Competitive Landscape - TipRanks
iTeos Therapeutics (NASDAQ:ITOS) Earns Outperform Rating from Wedbush - Defense World
iTeos fait le point sur ses activités et publie ses résultats financiers pour le quatrième trimestre et l’exercice 2024 - GlobeNewswire Inc.
H.C. Wainwright maintains Buy on ITOS with $21 price target By Investing.com - Investing.com Canada
iTeos Therapeutics Full Year 2024 Earnings: In Line With Expectations - Simply Wall St
iTeos Therapeutics: Undervalued with Promising Pipeline and Strong Financial Position - TipRanks
Y Intercept Hong Kong Ltd Purchases Shares of 18,468 iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
Iteos Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Iteos Therapeutics Inc expected to post a loss of $1.06 a shareEarnings Preview - TradingView
iTeos Therapeutics, Inc. SEC 10-K Report - TradingView
iTeos Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates - GlobeNewswire
Can iTeos' $655M War Chest Deliver on Its Promising Cancer Immunotherapy Pipeline? - StockTitan
iTeos Therapeutics (ITOS) to Release Earnings on Wednesday - Defense World
ITOS stock touches 52-week low at $7.09 amid market challenges - MSN
(ITOS) Technical Pivots with Risk Controls - Stock Traders Daily
iTeos Therapeutics: Decimated By Collateral Events, Good Chances Of Success Nevertheless - Seeking Alpha
Iteos Therapeutics stock hits 52-week low at $7.05 By Investing.com - Investing.com Canada
Iteos Therapeutics stock hits 52-week low at $7.05 - Investing.com India
Financial Contrast: enGene (NASDAQ:ENGN) versus iTeos Therapeutics (NASDAQ:ITOS) - Defense World
Short Interest in iTeos Therapeutics, Inc. (NASDAQ:ITOS) Increases By 5.2% - MarketBeat
Empowered Funds LLC Grows Stock Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World
iTeos Therapeutics (NASDAQ:ITOS) & Fate Therapeutics (NASDAQ:FATE) Head-To-Head Analysis - Defense World
Short Interest in iTeos Therapeutics, Inc. (NASDAQ:ITOS) Grows By 5.2% - Defense World
(ITOS) Investment Analysis and Advice - Stock Traders Daily
Peapod Lane Capital LLC Invests $836,000 in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - MarketBeat
iTeos Therapeutics, Inc. (NASDAQ:ITOS) Shares Acquired by SG Americas Securities LLC - Defense World
0.48%
자본화:
|
볼륨(24시간):